![aldevron-orange-background](./media_18344045516523d9aa2c9c3db88cb34c41e57b682.png?width=750&format=png&optimize=medium)
Eliminating Antibiotic Resistance Gene Transfer Risks in Cell & Gene Therapies
region | na1 |
portalId | 1769030 |
formId | 7dfe7f53-904c-47ef-83d9-6e7fdda3dbbb |
target | services-hubspot-form |
redirectUrl | https://www.aldevron.com/thank-you-for-downloading-eliminating-antibiotic-resistance-gene-transfer-risks-in-cell-and-gene-therapies |
Discover the Power of Small with NanoplasmidTM – A solution to eliminate antibiotic-resistant plasmids in cell & gene therapies.
![FierceBiotech_Aldevron_AntiBiotic_Whitepaper_Covers](./media_10d42f8f7b150825723aba8c08235049265c95d10.png?width=750&format=png&optimize=medium)
Download our whitepaper to learn about the drawbacks of antibiotic resistance that can cause side effects in patients and describes the Nanoplasmid’s antibiotic-free approach, a proactive strategy to:
- Meet or exceed regulator expectations
- Demonstrate value to increasingly cautious investors
- Ease Regulatory Concerns
- Shorten timelines
- Relieve manufacturing burden